Business Description
Wai Yuen Tong Medicine Holdings Ltd
ISIN : BMG9421Y2332
Total Employee Number:
691Compare
Compare
Traded in other countries / regions
00897.Hong Kong IPO Date
1997-10-31Description
Wai Yuen Tong Medicine Holdings Ltd is principally engaged in the manufacturing and sale of traditional Chinese pharmaceutical and health food products and relevant services, the manufacturing and sale of Western pharmaceutical, health food and personal care products, and property investment. The Group operates through the Chinese Pharmaceutical segment, which includes the manufacture, processing and sale of traditional Chinese medicine, Chinese medicinal products, health food products, TCM outpatient clinic services, and management and promotion services; the Western Pharmaceutical segment; and the Property Investment segment. The Chinese Pharmaceutical segment generates the maximum revenue, and the Group generates the maximum revenue from Hong Kong.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 15.92 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 0.96 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.7 | |||||
3-Year EBITDA Growth Rate | -5.7 | |||||
3-Year FCF Growth Rate | -22.8 | |||||
3-Year Book Growth Rate | -18.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.43 | |||||
9-Day RSI | 47.5 | |||||
14-Day RSI | 46.84 | |||||
3-1 Month Momentum % | -4.69 | |||||
6-1 Month Momentum % | -11.59 | |||||
12-1 Month Momentum % | -3.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 0.87 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 265.92 | |||||
Days Sales Outstanding | 32.97 | |||||
Days Payable | 26.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 2.6 | |||||
Shareholder Yield % | 23.5 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.96 | |||||
Operating Margin % | -2.47 | |||||
Net Margin % | 0.58 | |||||
EBITDA Margin % | 3.11 | |||||
FCF Margin % | 8.33 | |||||
OCF Margin % | 10.31 | |||||
ROE % | 0.34 | |||||
ROA % | 0.24 | |||||
ROIC % | -1.15 | |||||
ROC (Joel Greenblatt) % | 2.61 | |||||
ROCE % | 1.68 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 72.5 | |||||
PE Ratio without NRI | 36.25 | |||||
Price-to-Owner-Earnings | 6.17 | |||||
PS Ratio | 0.48 | |||||
PB Ratio | 0.27 | |||||
Price-to-Tangible-Book | 0.27 | |||||
Price-to-Free-Cash-Flow | 5.69 | |||||
Price-to-Operating-Cash-Flow | 4.68 | |||||
EV-to-EBIT | 24.15 | |||||
EV-to-EBITDA | 24.15 | |||||
EV-to-Revenue | 0.75 | |||||
EV-to-FCF | 9 | |||||
Price-to-GF-Value | 1 | |||||
Price-to-Projected-FCF | 0.15 | |||||
Price-to-Median-PS-Value | 4.14 | |||||
Price-to-Graham-Number | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 2.07 | |||||
Earnings Yield (Greenblatt) % | 4.14 | |||||
FCF Yield % | 17.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wai Yuen Tong Medicine Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 683.443 | ||
| EPS (TTM) (HK$) | 0.004 | ||
| Beta | 0.4547 | ||
| 3-Year Sharpe Ratio | 0.66 | ||
| 3-Year Sortino Ratio | 1.88 | ||
| Volatility % | 45.17 | ||
| 14-Day RSI | 46.84 | ||
| 14-Day ATR (HK$) | 0.009566 | ||
| 20-Day SMA (HK$) | 0.29425 | ||
| 12-1 Month Momentum % | -3.17 | ||
| 52-Week Range (HK$) | 0.265 - 0.51 | ||
| Shares Outstanding (Mil) | 1,114.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wai Yuen Tong Medicine Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wai Yuen Tong Medicine Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| 0.05:1 Stock Split | 2016-03-16 | 0.24 (+0.00%) | ||
| 0.04:1 Stock Split | 2010-09-22 | 3.41 (+3.23%) |
Show
Entries
Wai Yuen Tong Medicine Holdings Ltd Frequently Asked Questions
What is Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897)'s stock price today?
The current price of HKSE:00897 is HK$0.29. The 52 week high of HKSE:00897 is HK$0.51 and 52 week low is HK$0.27.
When is next earnings date of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897)?
The next earnings date of Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) is .
Does Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) pay dividends? If so, how much?
Wai Yuen Tong Medicine Holdings Ltd(HKSE:00897) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Wai Yuen Tong Medicine Holdings Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers